Infection and Immunity, February 2000, p. 767-778, Vol. 68, No. 2
0019-9567/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Department of Pathology and Laboratory Medicine, University of Texas at Houston Medical School, Houston, Texas
Received 15 October 1999/Accepted 9 November 1999
| |
ABSTRACT |
|---|
|
|
|---|
The mechanism of pathogenesis of Mycobacterium
tuberculosis is thought to be multifactorial. Among the putative
virulence factors is the antigen 85 (Ag85) complex. This family of
exported fibronectin-binding proteins consists of members
Ag85A, Ag85B, and Ag85C and is most prominently represented by 85A and
85B. These proteins have recently been shown to possess mycolyl
transferase activity and likely play a role in cell wall synthesis. The
purpose of this study was to generate strains of M. tuberculosis deficient in expression of the principal members of
this complex in order to determine their role in the pathogenesis of
M. tuberculosis. Constructs of fbpA and
fbpB disrupted with the kanamycin resistance marker
Km
and containing varying amounts of flanking gene and plasmid vector
sequences were then introduced as linear fragments into H37Rv by
electroporation. Southern blot and PCR analyses revealed disruption of
the homologous gene locus in one fbpA::
Km transformant and one fbpB::
Km transformant.
The fbpA::
Km mutant, LAa1, resulted from a
double-crossover integration event, whereas the
fbpB::
Km variant, LAb1, was the product of a
single-crossover type event that resulted in insertion of both
Km and plasmid sequences. Sodium dodecyl sulfate-polyacrylamide
gel electrophoresis and Western blot analysis confirmed that expression
of the disrupted gene was not detectable in the fbpA and
fbpB mutants. Analysis of growth rates demonstrated that
the fbpB mutant LAb1 grew at a rate similar to that of the
wild-type parent in enriched and nutrient-poor laboratory media as well
as in human (THP-1) and mouse (J774.1A) macrophage-like cell lines. The
fbpA mutant LAa1 grew similarly to the parent H37Rv in
enriched laboratory media but exhibited little or no growth in
nutrient-poor media and macrophage-like cell lines. The targeted
disruption of two genes encoding mycolyl transferase and
fibronectin-binding activities in M. tuberculosis will
permit the systematic determination of their roles in the physiology and pathogenesis of this organism.
| |
INTRODUCTION |
|---|
|
|
|---|
It has been estimated that one-third of the world's population is infected with Mycobacterium tuberculosis, the causative agent of the disease tuberculosis (24). The incidence of tuberculosis continues to increase worldwide, particularly among groups such as the medically underserved, the immunosuppressed, and the confined (11). New concerns have been raised by the reported increase in the overall number of cases, as well as by the increase in number of drug-resistant isolates (10, 11). Investigations into potential drug targets, more-efficient vaccines, and more-effective treatment regimens are currently under way in an effort to decrease morbidity and mortality due to this disease. While numerous immunogenic antigens and putative virulence factors have been isolated, cloned, and sequenced (36), insight into the mechanisms of pathogenesis of M. tuberculosis remains elusive.
The antigen 85 (Ag85) complex is a family of fibronectin-binding proteins that are considered to be potential virulence factors. These proteins (Ag85A, Ag85B, and Ag85C, encoded by the genes fbpA, fbpB, and fbpC, respectively) garnered attention when M. tuberculosis was found to bind selectively to fibronectin and not to other purified extracellular matrix proteins tested (32). Binding of these organisms to purified fibronectin is dose dependent and can be blocked by antibodies produced either to fibronectin or to members of the Ag85 complex (31, 32). It has been clearly demonstrated that the ability to bind fibronectin and other extracellular matrix proteins enhances the virulence of pathogenic organisms, most notably staphylococci and streptococci (28). Specific binding to host extracellular matrix proteins may aid in the adherence and dissemination of organisms in tissue.
Members of the Ag85 complex are both secreted and retained in the cell
wall of M. tuberculosis (1). Quantitatively, the proteins are secreted at a ratio of 3:2:1, Ag85A to Ag85B to Ag85C (15). These proteins have recently been found to possess
mycolyl transferase activity (9), adding to the growing
number of cell wall-synthetic enzymes identified in mycobacteria
(3, 4, 6, 10). Belisle et al. (9) identified
members of the Ag85 complex as enzymes responsible for the transfer of
mycolic acids to
-
'-trehalose to form
-
'-trehalose
monomycolate (TMM) and
-
'-trehalose dimycolate (TDM), also known
as cord factor. Ag85A and Ag85C share a similar specific mycolyl
transferase activity, while the specific activity of Ag85B is only
about 20% of that of Ag85C. One recent study (19) has shown
that a disruption mutant of a clinical isolate of M. tuberculosis deficient in Ag85C contained 40% less cell
wall-bound mycolates than the parent strain. These mycolates
represented not only TMM and TDM but also other molecules such as
arabinogalactan, glycerol monomycolate,
-mycolates, methoxymycolates, and ketomycolates. There was no apparent change in
the composition of mycolates detected, but their quantity was affected
by mutation of Ag85C. It remains to be determined why mycobacteria
possess three enzymes with apparently similar activities and whether
the individual members of the Ag85 complex play different roles in the
production of these molecules.
In this study, several constructs were utilized in an attempt to achieve homologous recombination and disruptional mutagenesis of fbpA and fbpB in the virulent M. tuberculosis strain H37Rv. PCR, Southern blot hybridization, sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE), and immunoblot analyses confirmed the disruption and inactivation of fbpA and fbpB in individual strains of M. tuberculosis. Loss of FbpA expression was shown to inhibit the ability of H37Rv to grow in wholly synthetic media or to replicate in human or mouse macrophage-like cell lines, indicating that FbpA may play a role in the pathogenesis of M. tuberculosis.
| |
MATERIALS AND METHODS |
|---|
|
|
|---|
Bacterial strains and media.
Middlebrook media were
purchased from Difco Laboratories, Detroit, Mich. The virulent
laboratory strain of M. tuberculosis, H37Rv (ATCC 27294),
was grown in liquid Middlebrook 7H9 medium supplemented with 0.2%
glycerol, 0.25% Tween 80 (Sigma Chemical Co., St. Louis, Mo.), and
albumin-dextrose complex (ADC) (consisting of 0.5% bovine serum
albumin, fraction V [Sigma], 0.085% NaCl, and 0.2% glucose) or
Sauton medium (25). Middlebrook 7H10 or 7H11 plates
supplemented with ADC with or without 20 µg of kanamycin/ml were used
for colony isolation. Cycloheximide at 50 µg/ml was added to all
plates to inhibit growth of fungi during incubation. Escherichia
coli DH5
1 (Stratagene, La Jolla, Calif.) was used for
recombinant DNA studies and plasmid propagation. These strains were
grown on solid or liquid Luria-Bertani (LB) medium (34) supplemented with 50 µg of kanamycin/ml as indicated.
Macrophage cell lines and media. The human monocyte-like cell line THP-1 (ATCC TIB-202) and the murine monocyte-like cell line J774A1 (ATCC TIB-67) were maintained in nitrate-free RPMI 1640 medium (GIBCO BRL, Grand Island, N.Y.) supplemented with 50 mg of HEPES/liter, 200 mM glutamine, 2.2 g of sodium bicarbonate/liter, 50 mg of L-arginine/liter, 100 U of penicillin/ml, 50 µg of gentamicin/ml, and either 10% heat-inactivated human AB serum (for THP-1 cells) or 10% heat-inactivated fetal bovine serum (FBS) (for J774A1 cells). Cells for use in M. tuberculosis cocultures were expanded in media without antibiotics and harvested during log phase.
Recombinant DNA techniques.
To isolate chromosomal DNA,
M. tuberculosis cells were grown to confluence on
Löwenstein-Jensen slants at 37°C under 9.5% CO2.
Cells were scraped from the surface of the slant and resuspended in 500 µl of TE buffer (10 mM Tris-1 mM EDTA [pH 8]) in a 1.5-ml microcentrifuge tube. Two milligrams of achromopeptidase (Sigma) per
milliliter was added, and the samples were incubated for 1 h at
37°C. At that time, 120 µg of proteinase K/ml and 1.5% SDS were
added, and samples were incubated for 10 min at 65°C.
N-cetyl-N,N,N-trimethyl ammonium
bromide (1.3%, vol/vol) was added, and the samples were incubated for
another 10 min at 65°C. These samples were then extracted twice with
phenol-chloroform (1:1) and once with chloroform-isoamyl alcohol (24:1)
and were ethanol precipitated. DNA was pelleted and resuspended in an
appropriate volume of TE buffer. Molecular cloning and restriction
endonuclease digestion were performed by standard techniques
(34). Cloning vectors used were pBluescript KS(+)
(Stratagene) and pNEB193 (New England Biolabs, Beverly, Mass.).
Restriction endonucleases and other enzymes (New England Biolabs;
Promega, Madison, Wis.) were used according to the manufacturers' instructions. The
Km cassette in plasmid pHP45
Km (14)
was graciously provided by the laboratory of Malcolm Winkler,
Department of Microbiology and Molecular Genetics, University of
Texas
Houston Medical School.
Generation of transforming plasmids.
A 9.4-kb
BamHI/ClaI fragment containing the H37Rv
fbpA gene was cloned into pBluescript KS by standard methods
(34) and identified by Southern blot hybridization using a
PCR-generated fragment of fbpA as a probe. An internal
750-bp ApaI fragment was subcloned into pBluescript KS(+),
excised by using the vector KpnI and EcoRI sites,
and then ligated into pNEB193 linearized with the same two enzymes. The
resultant plasmid, pLYAa6, was linearized at the unique
SacII site within fbpA (see Fig. 1) and treated
with the Klenow fragment of DNA polymerase I to provide blunt ends. A
blunt-ended
Km cassette was prepared by liberating the
Km
fragment from pHP45
Km with EcoRI and treating the
resultant fragment with the Klenow fragment. The blunt-ended pLYAa6 and
Km DNA fragments were ligated to generate plasmid pLYAa6
Km, containing an fbpA::
Km gene disruption (see Fig. 1).
An internal 500-bp AccI fragment was subcloned directly into
the AccI site of pNEB193 and likewise interrupted with the
Km cassette at the SacII site to generate the
transforming plasmid pLYAa4
Km (see Fig. 1).
Km gene disruptions, a 6.6-kb
EcoRI/HindIII fragment containing the
fbpB gene of H37Rv was cloned into the EcoRI and
HindIII sites of pBluescript KS. An internal 750-bp
SacII fragment was subcloned into pBluescript KS and then
into pNEB193 by using the vector SacI and XbaI
sites to generate pLYAb5. This plasmid was linearized with
EcoRV and ligated with a blunt-ended
Km cassette,
prepared as described above, to generate plasmid pLYAb5
Km
(Fig. 1). A 2.3-kb HindIII/NcoI
fragment containing fbpB was subcloned into pNEB193 to
generate pLYAb3. This plasmid was mutated by addition of a blunt-ended
Km cassette at the unique EcoRV site within
fbpB to generate pLYAb3
Km (Fig. 1).
To prepare the DNA for transformation of M. tuberculosis,
plasmids pLYAa4
Km and pLYAb5
Km were linearized with
SacI and pLYAa6
Km was linearized with ClaI
(Fig. 1). In addition, pLYAa6
Km and pLYAb5
Km were treated with
ApaI and SacII, respectively, to yield the
mutated genes without vector sequences.
The shuttle plasmid pLYAspk was generated by cloning the 3-kb
KpnI/EcoRV origin of replication fragment of the
Mycobacterium fortuitum plasmid pAL5000 from the recombinant
plasmid pYUB18 (20) into pBluescript KS and cloning the
Km marker into the unique BamHI site. This plasmid is
able to replicate in both E. coli and M. tuberculosis and to confer kanamycin resistance.
Electroporation of M. tuberculosis H37Rv.
M.
tuberculosis H37Rv was prepared for electroporation as previously
described (20). Briefly, cells were grown in Middlebrook 7H9
medium-ADC-Tween 80 with gentle shaking to an optical density at 600 nm of 0.6 to 1.0, washed three times in 1/50 volume of cold 10%
glycerol, resuspended in 10% glycerol at a concentration of
~1011 cells/ml, and stored at
70°C until needed. The
linearized plasmids (2 to 4 µg of DNA) diagrammed in Fig. 1 were
electroporated at 0°C into 1010 electrocompetent H37Rv
cells by using an Electroporator 2510 (Eppendorf North America,
Madison, Wis.) at a setting of 1,250 V; under these conditions, the
pulse time was 4 to 5 ms. One milliliter of 7H9-ADC broth without
antibiotics was added immediately, and the bacteria were incubated at
37°C for 2.5 h with agitation. Transformants were then plated on
7H10-ADC-kanamycin plates and incubated at 37°C for 3 weeks under
9.3% CO2. Individual kanamycin-resistant colonies were
subcultured onto fresh 7H10-ADC-kanamycin plates and grown an
additional 2 to 3 weeks prior to further evaluation.
Hybridization analysis.
Fluorescein conjugation of the DNA
fragments used as probes and chemiluminescent detection of
hybridization were carried out according to the GeneImages procedure
(Amersham Life Science Inc., Arlington Heights, Ill.). For initial
screening of transformants, chromosomal DNA liberated from boiled
M. tuberculosis colonies was immobilized onto a Hybond N+
nylon membrane (Amersham Life Science Inc.) by using a slot blot
apparatus. Immobilized DNA was hybridized with a fluorescein-labeled
700-bp fragment from the
Km cassette obtained by digestion with
PvuII, agarose gel separation, and purification using the
PCR Cleanup kit (Promega). In addition, intact chromosomal DNA was
digested with the enzymes indicated in Fig. 3, electrophoresed in 0.7%
agarose, and transferred to a nylon membrane by using the alkaline
transfer procedure (34). The membrane was then hybridized
with a fluorescein-labeled probe (either the internal 750-bp
ApaI fragment from fbpA or the internal 750-bp
SacII fragment from fbpB).
PCR.
Primers used in this study are listed in Table
1. PCR was performed to screen for
disruptions in fbpA (see Fig. 2) and fbpB (data
not shown). Two primers were unique to the upstream regions of
fbpA (5'A2) and fbpB (5'B2), and one primer was
common to both fbpA and fbpB (3'AB). The primers
5'
Km and 3'
Km were used to screen for the presence of the
Km
cassette. Cells (104 to 106 per reaction) from
transformants were boiled in TE buffer for 10 min to liberate
chromosomal DNA, which was used as a template. PCR conditions were 10 mM Tris (pH 8.8), 1.5 mM MgCl2, 50 mM KCl, 0.1% Triton
X-100, 200 µM deoxynucleoside triphosphates, 0.5 µM each primer,
and 2 U of Thermalase polymerase (Amresco, Solon, Ohio) per 100 µl of
reaction mixture. Denaturation, annealing, and extension temperatures
(and times) were as follows: 1 cycle of 96°C for 2 min; 5 cycles of
94°C for 40 s, 56°C for 40 s, and 72°C for 1.5 min; 30 cycles of 94°C for 40 s, 68°C for 40 s, and 72°C for
1.5 min; and a final extension of 72°C for 10 min.
|
Sequence analysis.
The PCR primer pairs 5'A2 and 3'
Km2
and 5'
Km2 and 3'Aexp (see Fig. 2) were used to amplify
the 5' and 3' regions, respectively, of the fbpA gene locus
in LAa1. Primers 3'
Km2 and 5'
Km2 are specific for sequences
within the
Km cassette. PCR primers 5'B2 and 3'
Km2 were used to
amplify the 5' region of the fbpB locus of LAb1. Southern
blot analysis revealed that the transforming vector pNEB193 had
integrated into the fbpB locus. Primer pNEB1, which is
specific for pNEB193, was used with 3'Bexp to amplify the
3' region of LAb1. PCR products were purified, desalted, and used
directly as templates for sequencing. DNA sequencing was performed by
using an ABI 377 automatic DNA sequencer (Perkin-Elmer/Applied Biosystems, Foster City, Calif.) at the DNA Core Laboratory, Department of Microbiology and Molecular Genetics, University of Texas-Houston Medical School. Sequences were analyzed with the GAP and BESTFIT programs (Genetics Computer Group, Madison, Wis.).
SDS-PAGE and Western blot analysis.
The parent strain,
H37Rv, and the fbpA::
Km and
fbpB::
Km mutants were grown in stationary cultures
(without agitation) in Middlebrook 7H9 broth without additional
supplements, except 20 µg of kanamycin/ml for selection of the two
mutant strains. Five milliliters of 11-day cultures were filtered twice
through a 22-µm-pore-size filter. Two milliliters of each filtrate
was concentrated to ~150 µl by using a Centricon-10 membrane
apparatus (Amicon, Beverly, Mass.). The retentates were resuspended in
an equal volume of solubilization buffer (2% SDS, 5%
2-mercaptoethanol, 10% glycerol). Proteins were electrophoresed in
8-to-20% polyacrylamide gradient gels and stained with Coomassie blue
or transferred to polyvinyl difluoride (PVDF) membranes as previously
described (27). Western blot analysis was carried out by
incubating PVDF membranes with a 1:100 dilution of hybridoma culture
supernatant containing the monoclonal antibody HYT27 (1),
kindly provided by T. M. Shinnick, Centers for Disease Control and
Prevention, Atlanta, Ga. This antibody has been shown to react with
FbpA, FbpB, and FbpC. Second antibody incubation and detection were
carried out according to the GeneImages procedure (Amersham).
In vitro growth studies. The parent strain, H37Rv, and the fbpA and fbpB mutants were washed with saline and added at 104 CFU/ml to the enriched Middlebrook 7H9-ADC and synthetic Sauton media and incubated with gentle mixing at 37°C for 14 days. On days 3, 5, 7, 10, and 14, aliquots were removed from each broth culture and plated in 10-fold dilutions on 7H10-ADC plates with or without kanamycin for colony counts.
Infection of macrophages. Macrophage infections were carried out as previously described (21, 22). Briefly, THP-1 cells were washed three times in the RPMI 1640 assay medium described above but with 2% AB serum, 1 µg of tetrahydrobiopterin/ml, and no antibiotics. Suspensions of M. tuberculosis H37Rv or the fbpA or fbpB mutant were dispersed by gentle sonication and mixed with 108 THP-1 cells at a concentration of 1010 CFU in 5 ml of assay medium. Phagocytosis was allowed to occur for 4 h with gentle mixing at 37°C. Cells were then washed by low-speed centrifugation and resuspension in assay medium six times, diluted to 106 cells/ml, and plated at 1 ml per well in 24-well culture plates. For infection of J774A1 cell cultures, adherent monolayers were established in 24-well plates by using RPMI 1640 assay medium with 10% FBS. Monolayers were infected at a CFU/macrophage ratio of 1:1 for 4 h with gentle mixing at 37°C. The monolayers were then washed extensively with warm assay medium. Twenty-four-well plates with infected THP-1 and J774A1 cells were incubated at 37°C under 5% CO2, and 1 ml of fresh assay medium was added to each well on day 3. Aliquots of THP-1 cells and supernatants were aspirated from wells, pelleted, and lysed with 0.05% SDS in saline, while J774A1 cells were lysed in situ on days 0 (baseline CFU), 3, 5, and 7 (three replicates per time point). SDS lysates were neutralized by the addition of sterile 15% bovine serum albumin in saline, and lysates were diluted in sterile saline. Serial 10-fold dilutions of the diluents were plated out on 7H11 agar for CFU counts. Controls for extracellular growth of M. tuberculosis were obtained by incubating 104 CFU of M. tuberculosis H37Rv/ml in 1 ml of assay medium containing a sonicated lysate of 106 THP-1 macrophages which had been passed through a 0.22-µm-pore-size filter to remove cell debris. Heat-inactivated human AB serum does not support M. tuberculosis growth, nor does M. tuberculosis grow in RPMI 1640 assay medium containing macrophage lysate and 5% heat-inactivated AB serum (data not shown).
Electron microscopic examination of M. tuberculosis-infected THP-1 cells. On day 7 post-macrophage infection, aliquots of THP-1 cells infected with H37Rv or LAa1 were aspirated from wells, pelleted, and washed with phosphate-buffered saline three times. The cells were then prepared for electron microscopy as previously described (16).
| |
RESULTS |
|---|
|
|
|---|
Transformation of M. tuberculosis.
H37Rv was transformed
by electroporation with 2 to 4 µg of several linearized constructs
containing the fbpA and fbpB genes interrupted by
the
Km cassette (Fig. 1). The
transforming fragments contained between 74 and 585 bp of the M. tuberculosis sequences on either side of the
Km insert; in some
cases the vector sequences were retained to protect the construct from
potential exonuclease activity. These constructs lacked an origin of
replication active in M. tuberculosis; therefore, kanamycin
resistance could be conferred only if part or all of the transforming
fragment was integrated into the M. tuberculosis chromosome.
Plasmid pLYAspk, which contains the
Km cassette and is capable of
replication in both M. tuberculosis and E. coli,
was used as a positive control for transformation. Following
electroporation, the transformation mixtures (originally containing
~1010 M. tuberculosis cells) were plated on
7H10-ADC-kanamycin plates to select for kanamycin-resistant
(Kmr) colonies. To assess the rate of Kmr due
to spontaneous mutation versus integration or recombination events,
transformants were subjected to slot blot analysis using a 700-bp
fragment of
Km as the probe.
|
Km and
fbpB::
Km constructs. However, 17 Kmr
colonies were identified in the negative control without
transforming DNA, indicating the occurrence of spontaneous
mutations leading to Kmr. Indeed, only a small proportion
of the Kmr colonies representing organisms
transformed with fbpA::
Km or fbpB::
Km constructs contained
Km, as
determined by slot blot analysis (Table 2). Two constructs, pLYAa6
Km
and pLYAb5
Km, integrated into the chromosome in 3 of 10 (30%) and 9 of 26 (34.6%) of the Kmr colonies screened (Table 2).
Recombinants containing the
Km cassettes were not detected in the
limited number of clones examined from the other transformation groups.
|
PCR screening.
To identify H37Rv clones with the desired
fbpA::
Km and fbpB::
Km gene
disruptions, a PCR strategy was devised to amplify the region where the
targeted disruption was to occur. Each PCR mixture contained a primer
unique to the upstream region of fbpA (5'A2), a primer
unique to the upstream region of fbpB (5'B2), and a primer
that was common to both (3'AB) (Fig. 2A).
Under the PCR amplification conditions used, an integrative or
recombinative event at one or the other gene locus would result in a
corresponding loss of product. The amplification of both genes thus
provided an internal PCR control.
|
Km and fbpB::
Km
transformations were screened in this manner. The results of several of
the fbpA::
Km transformants are shown in Fig. 2A. Most of the amplification reactions resulted in an intact fbpA
product (600 bp) and an intact fbpB product (300 bp).
Transformants that contained the fbpB PCR product but lacked
the fbpA PCR product were chosen for further analysis.
Additional primers specific for
Km and different regions of
fbpA (Fig. 2B) were used to further characterize the mutants
by PCR. One fbpA::
Km transformant was found to have a
disruption in the 5' region of the gene, while the 3' region was
intact. By using primers to
Km sequences, this transformant was
found to contain the
Km cassette (Fig. 2B, rightmost panel). The
Km cassette was used as a positive control in this case. Four
fbpB::
Km transformants were analyzed in a similar manner, and one was found by PCR to contain a 5' disruption of fbpB, an intact 3' region, and
Km sequences (data not
shown). Screening was discontinued when single
fbpA::
Km and fbpB::
Km mutants were
obtained. These two disruption mutants were analyzed further.
Southern blot analysis of fbpA::
Km and
fbpB::
Km mutants.
Digestion of wild-type H37Rv
chromosomal DNA with the restriction endonuclease ApaI
generates a 750-bp fbpA gene fragment (Fig. 1), while
digestion with EcoRI generates a 5-kb fragment with the
1,059-bp fbpA gene located near the center (12).
When chromosomal DNA from the fbpA::
Km mutant was
digested with ApaI and probed with a PCR-generated
fbpA fragment, it was found to lack the 750-bp native gene
fragment. Instead, it now contained a 3-kb fragment identical in size
to the transforming DNA fragment (Fig.
3A). Digestion of DNA from this
transformant with EcoRI revealed that the locus had
undergone an increase in size roughly equivalent to the size of the
Km cassette (~2.3 kb). In addition, EcoRI-digested DNA
from the transformant was probed with the labeled transforming vector,
pNEB193, and vector sequences were found to be absent (Fig. 3C). These
data are consistent with the occurrence of a double-crossover
recombination event at the fbpA locus.
|
Km mutant
was evaluated in a similar manner. Digestion of H37Rv chromosomal DNA
with the restriction endonuclease SacII generates an
fbpB gene fragment of approximately 750 bp, and digestion
with KpnI generates a ~7-kb fragment containing
fbpB. Analysis of the fbpB::
Km mutant by digestion with SacII and KpnI and Southern blot
hybridization with the labeled 750-bp SacII fbpB
gene fragment revealed the presence of the native gene fragment in
addition to the transforming fragment (Fig. 3B). This result is
consistent with an integrative event in which both
fbpB::
Km and vector sequences were inserted at the
native fbpB site. This interpretation was corroborated by
the fact that the 7-kb KpnI fragment increased to ~12 kb
in the fbpB::
Km mutant. Thus, the pLYAb5
Km
fragment was inserted at the native gene locus through a
single-crossover event near the 5' end, as supported by the presence of
vector sequences at this site (Fig. 3C). The fbpA::
Km
and fbpB::
Km mutants were designated LAa1 and LAb1, respectively.
Sequence analysis.
Sequence analysis was performed on LAa1 and
LAb1 to characterize the recombination events that had occurred.
Analysis of the 5' and 3' regions of the fbpA gene sequences
flanking the
Km cassette in LAa1 revealed that the sequences were
identical to those of the wild-type gene in these regions (data
not shown). These results were consistent with a
double-crossover, homologous-recombination event within the
fbpA gene (Fig. 4A). Sequence
analysis of the 5' region of LAb1 also revealed sequence identity to
wild-type fbpB in this region. The sequence downstream of
the
Km cassette was identical to the end of the construct
pLYAb5
Km (including the segment of pNEB193), indicating that this
region was integrated in its entirety into the
fbpB::
Km gene locus. Surprisingly, the 3' end of the
inserted sequence terminated at the SacI site used for
linearization of the transforming fragment (Fig. 4C); therefore, no
degradation of the end of the insert occurred before integration. Following the insert sequence, the wild-type fbpB gene
resumed at bp 107 of the open reading frame, marking the exact point of insertion. A model of the integrative event occurring in LAb1 is shown
in Fig. 4B.
|
SDS-PAGE and Western blot analysis. To verify that the chromosomal mutations in LAa1 and LAb1 disrupted synthesis of FbpA and FbpB, respectively, concentrated supernatant proteins and whole-cell lysates from wild-type H37Rv and the two mutants were analyzed by SDS-PAGE. Results for supernatant and lysate proteins were the same. As demonstrated in Fig. 5A, the parent, H37Rv, had two prominent protein bands at 32 kDa (representing FbpA) and 31 kDa (representing FbpB). The FbpA band was absent in LAa1, while the other visible protein bands were all intact. Likewise, the protein band representing FbpB was absent in LAb1. Western blot analysis with monoclonal antibody HYT27 confirmed these results (Fig. 5B). HYT27 is reactive with all members of the Ag85 complex and bound specifically to the FbpA and FbpB bands in H37Rv, the FbpB band only in LAa1, and the FbpA band in LAb1. The quantity of FbpC was apparently too low in these preparations to be detected by these techniques.
|
In vitro growth studies. Since the Ag85 complex has been identified as having mycolyl transferase activity, the fbpA and fbpB mutants were anticipated to display differences during in vitro culture. In order to test this hypothesis, the parent and mutant strains were cultured in enriched Middlebrook 7H9-ADC broth or Sauton broth, a commonly used synthetic medium. While all three strains grew in the Middlebrook 7H9-ADC broth at very similar rates, the fbpA mutant, LAa1, was unable to grow in the synthetic Sauton medium (Fig. 6).
|
Macrophage infection studies.
The macrophage cell line culture
method can be used to measure differences in capacity for
intracellular growth among strains of mycobacteria (21, 22).
Human THP-1 macrophage cultures were infected with H37Rv and with the
fbpA and fbpB mutants LAa1 and LAb1 to
determine intracellular growth. In this system, the parent strain,
H37Rv, increased in number from 104 to
106
mycobacteria per culture over a 7-day incubation period (Fig. 7). These results are similar to those
obtained with M. tuberculosis Erdman in the same system
(22). The fbpB mutant, LAb1, exhibited a similar
growth curve. However, the fbpA mutant, LAa1, actually decreased in number under the same incubation conditions, indicating an
inability to survive and replicate in macrophages (Fig. 7B). Monolayers
of the J774A1 murine macrophage cell line also supported the growth of
the parent strain, H37Rv, and the fbpB mutant, whereas the
fbpA mutant did not replicate (Fig. 7A). Examination by
electron microscopy (Fig. 8A) revealed
that infection of THP-1 cells by H37Rv resulted in high numbers of
intact, intracellular mycobacteria. In contrast, LAa1 infection
resulted in fewer mycobacteria that were rarely intact and exhibited
varying degrees of degradation. LAa1-infected cells also had many
extensions indicative of membrane ruffling and cell activation (Fig.
8B), whereas H37Rv-infected cells appeared relatively quiescent.
|
|
| |
DISCUSSION |
|---|
|
|
|---|
While homologous recombination with gene replacement has been demonstrated readily in fast-growing, nonpathogenic mycobacteria, such as Mycobacterium smegmatis (17), generation of defined mutations in the genomes of slow-growing mycobacteria initially proved difficult. Attempts to achieve homologous recombination in M. tuberculosis and Mycobacterium bovis BCG revealed a high rate of illegitimate recombination, with random insertion of linear DNA fragments into the chromosome (23, 35). Despite this finding, intraplasmic (8, 26) and interplasmic (8) recombination experiments have demonstrated that homologous recombination does occur in slow-growing mycobacteria, although at a significantly lower rate than illegitimate recombination. Aldovini et al. (2) obtained recombination without gene replacement at the chromosomal uraA site of M. bovis BCG, producing transformants that had undergone single-crossover homologous recombination at only one end of the transforming fragment. These results indicated that disruption could be achieved by using fragments internal to the coding region of a gene. Other studies involving the use of linear DNA fragments of single-gene length (4, 33), linear DNA fragments of 40 to 50 kb (5), transposon delivery systems (7, 29, 30), and SacB counterselection plasmids (3, 30) have proven successful with increasing frequency. Despite the increased proficiency at mutagenesis of the M. tuberculosis chromosome, the list of identified potential virulence factors remains brief.
In this study, several constructs were utilized in our attempts to
disrupt the fbpA and fbpB chromosomal loci in
M. tuberculosis (Fig. 1). The size of the M. tuberculosis DNA insert ranged from 0.5 to 2.3 kb, and the amount
of M. tuberculosis DNA flanking the
Km cassette ranged
from 74 bp to 1.3 kb. Linear constructs with and without flanking
vector sequences were used. Each of the six constructs tested was
modeled after prior attempts to disrupt genes in M. tuberculosis (2, 23, 26). We reasoned that using
several constructs would increase the likelihood of gene disruption.
Insertional mutants were obtained for both fbpA and
fbpB. Of the six constructs utilized for transformation in
this study, only two yielded H37Rv clones containing
Km cassettes
(Table 2). Both of these (pLYAa6
Km, treated with ClaI,
and pLYAb5
Km, treated with SacI) had relatively small
M. tuberculosis DNA inserts (~750 bp) and contained
flanking vector DNA. Although the number of clones examined was too
small for statistical analysis, we can conclude that insertional
mutagenesis of M. tuberculosis genes can be achieved with
small inserts and may be aided by the presence of flanking vector
sequences. Our efforts were focused on the single
fbpA::
Km and fbpB::
Km mutants
described here, but it is likely that additional site-specific
mutations could be identified with additional screening.
In the case of fbpA, mutagenesis occurred by
double-crossover homologous recombination, resulting in an insertion of
Km into the chromosomal fbpA site. This result was
confirmed by PCR, Southern blot, and sequence analyses. PCR results
using primers within fbpA and
Km and primers outside the
region used for transformation were consistent with a double-crossover
event without addition of extraneous DNA. By Southern blot analysis,
there is an increase in size at the native fbpA gene locus
equal to the size of the
Km cassette. Sequence data confirmed
addition of the
Km cassette at the SacII site of
fbpA without addition or deletion of base pairs. With regard
to fbpB, Southern blot analysis revealed that the entire
transforming fragment, including the vector pNEB193, had integrated
into the chromosome. Sequencing of this region demonstrated the
occurrence of homologous recombination at the 5' end of the gene with a
double-stranded break and insertion of the nonhomologous vector
sequence adjacent to the fbpB chromosomal sequences at the
3' end.
Results of previous attempts to mutate individual genes in slow-growing
mycobacteria using chromosomal fragments mutated with a kanamycin
resistance marker have suggested a predominance of illegitimate over
legitimate recombination. This was based on the presence of a high
number of antibiotic-resistant colonies in the absence of the desired
gene disruption. Our studies suggest that there is a high rate of
spontaneous kanamycin resistance in these organisms and that a large
number of the Kmr colonies reported previously were due to
spontaneous mutation rather than illegitimate recombination. Of the 118 Kmr colonies that we screened (Table 2), 106 (90%) were
spontaneous kanamycin mutants, in that slot blot analysis revealed the
absence of the kanamycin resistance marker. Of the remaining 12 transformants that were found to have integrated the
Km cassette
into their chromosomes, only 2 (17%) had undergone integration at the
homologous gene loci. Previous studies have involved screening of
transformants for the desired mutation by looking for a phenotypic
change (i.e., auxotrophy or urease activity) and have not addressed the
rate of spontaneous mutation. We have found that the rate of
spontaneous mutation is somehow increased by the electroporation of DNA
but not by the act of electroporation itself (unpublished data). As an
example, the rate of spontaneous mutation was lower under control conditions where no DNA was used during electroporation (Table 2).
Members of the Ag85 complex have been found to possess mycolyl transferase activity. Since disruption of members of the complex could potentially affect cell wall synthesis, we examined the abilities of the two mutants, LAa1 and LAb1, to grow in routine laboratory media, one ADC-containing medium and one minimal medium composed of basic salts with no supplements. There was no significant difference in the growth rates of the mutant strains compared to that of the parent strain in media containing ADC (Fig. 6A). In contrast, the fbpA mutant, LAa1, exhibited little growth in a minimal medium that lacked ADC (Fig. 6B). Albumin-containing enrichments are added to the growth media of mycobacteria primarily to bind toxic lipid byproducts produced during routine growth in the presence of lipids such as Tween 80. The albumin-oleate complex also acts as an additional nutrient source for the organisms. The lack of growth of the fbpA mutant in minimal medium may indicate an increased dependence on lipids or other compounds associated with albumin in the enriched medium. In macrophage-like cell line infection models with both human and mouse cell lines, disruption of Ag85B again had no obvious effect on growth compared to that of the parent strain while the Ag85A mutant, LAa1, was severely hampered in its growth (Fig. 7). The number of CFU of LAa1 actually decreased during macrophage cell line infection, and killing of the mycobacteria by macrophages was verified by electron microscopy (Fig. 8A). Poor survival of LAa1 in macrophages may reflect an alteration in phagosome processing such that the mycobacteria are exposed to lysosomal contents or phagosome acidification (13). Alternatively, the increased dependence on nutritional compounds observed in broth cultures could result in decreased survival and growth in the intracellular compartment. These possibilities will be addressed in subsequent studies.
It has been postulated that the members of the Ag85 complex, though closely related, are not coordinately regulated (15). In keeping with this hypothesis, we found no evidence in our mutants that expression of the other genes of the complex increased or decreased quantitatively in response to the loss of one of the members (Fig. 5). The same study also demonstrated that the genes are transcribed as monocistronic messages, decreasing the likelihood that the effects seen in this study are due to a polar effect on genes downstream of the fbpA gene locus.
Much speculation has been made about the roles of the individual members of the Ag85 complex. Although they all have mycolyl transferase activity, there is clear evidence that the efficiency at which this reaction is carried out differs among the three proteins (9). Studies have shown that naked DNA vectors containing the Ag85A gene injected into mice afforded a promising degree of protection as a vaccine against M. tuberculosis infection (18), which would seem to indicate a role for the Ag85 complex in the immunology of this process. Mutation of individual members of this complex will aid in determining the individual roles of these proteins in the pathogenesis and immunology of mycobacterial infection as well as in the synthesis of the mycobacterial cell wall.
| |
ACKNOWLEDGMENTS |
|---|
We thank T. M. Shinnick, Centers for Disease Control and
Prevention, for providing monoclonal antibodies, M. E. Winkler,
Department of Microbiology and Molecular Genetics, University of
Texas
Houston Medical School, for supplying plasmid pHP45
Km, and
W. R. Jacobs, Department of Microbiology and Immunology,
Howard Hughes Medical Institute, Albert Einstein College of
Medicine, Bronx, N.Y., for providing plasmid pYUB18. We also thank
G. M. Weinstock, H. B. Kaplan, E. M. Walker, and S. Mueller for invaluable advice and discussions, Betty Boulet and Emem
Akpaffiong for technical assistance, and Patricia Navarro for electron microscopy.
| |
FOOTNOTES |
|---|
* Corresponding author. Mailing address: Department of Pathology and Laboratory Medicine, 6431 Fannin St., Houston, TX 77030. Phone: (713) 500-5272. Fax: (713) 500-0730. E-mail: armitige{at}casper.med.uth.tmc.edu.
Editor: D. L. Burns
| |
REFERENCES |
|---|
|
|
|---|
| 1. |
Abou-Zeid, C.,
T. L. Ratliff,
H. G. Wiker,
M. Harboe,
J. Bennedsen, and G. A. Rook.
1988.
Characterization of fibronectin-binding antigens released by Mycobacterium tuberculosis and Mycobacterium bovis BCG.
Infect. Immun.
56:3046-3051 |
| 2. |
Aldovini, A.,
R. N. Husson, and R. A. Young.
1993.
The uraA locus and homologous recombination in Mycobacterium bovis BCG.
J. Bacteriol.
175:7282-7289 |
| 3. |
Azad, A. K.,
T. D. Sirakova,
N. D. Fernandes, and P. E. Kolattukudy.
1997.
Gene knockout reveals a novel gene cluster for the synthesis of a class of cell wall lipids unique to pathogenic mycobacteria.
J. Biol. Chem.
272:16741-16745 |
| 4. |
Azad, A. K.,
T. D. Sirakova,
L. M. Rogers, and P. E. Kolattukudy.
1996.
Targeted replacement of the mycocerosic acid synthase gene in Mycobacterium bovis BCG produces a mutant that lacks mycosides.
Proc. Natl. Acad. Sci. USA
93:4787-4792 |
| 5. |
Balasubramanian, V.,
M. S. Pavelka, Jr.,
S. S. Bardarov,
J. Martin,
T. R. Weisbrod,
R. A. McAdam,
B. R. Bloom, and W. R. Jacobs, Jr.
1996.
Allelic exchange in Mycobacterium tuberculosis with long linear recombination substrates.
J. Bacteriol.
178:273-279 |
| 6. |
Banerjee, A.,
E. Dubnau,
A. Quemard,
V. Balasubramanian,
K. S. Um,
T. Wilson,
D. Collins,
G. de Lisle, and W. R. Jacobs, Jr.
1994.
inhA, a gene encoding a target for isoniazid and ethionamide in Mycobacterium tuberculosis.
Science
263:227-230 |
| 7. |
Bardarov, S.,
J. Kriakov,
C. Carriere,
S. Yu,
C. Vaamonde,
R. A. McAdam,
B. R. Bloom,
G. F. Hatfull, and W. R. Jacobs, Jr.
1997.
Conditionally replicating mycobacteriophages: a system for transposon delivery to Mycobacterium tuberculosis.
Proc. Natl. Acad. Sci. USA
94:10961-10966 |
| 8. |
Baulard, A.,
L. Kremer, and C. Locht.
1996.
Efficient homologous recombination in fast-growing and slow-growing mycobacteria.
J. Bacteriol.
178:3091-3098 |
| 9. |
Belisle, J. T.,
V. D. Vissa,
T. Sievert,
K. Takayama,
P. J. Brennan, and G. S. Besra.
1997.
Role of the major antigen of Mycobacterium tuberculosis in cell wall biogenesis.
Science
276:1420-1422 |
| 10. | Blanchard, J. S. 1996. Molecular mechanisms of drug resistance in Mycobacterium tuberculosis. Annu. Rev. Biochem. 65:215-239[CrossRef][Medline]. |
| 11. |
Bloom, B. R., and C. J. L. Murray.
1992.
Tuberculosis: commentary on a reemergent killer.
Science
257:1055-1064 |
| 12. |
Borremans, M.,
L. de Wit,
G. Volckaert,
J. Ooms,
J. de Bruyn,
K. Huygen,
J. P. van Vooren,
M. Stelandre,
R. Verhofstadt, and J. Content.
1989.
Cloning, sequence determination, and expression of a 32-kilodalton-protein gene of Mycobacterium tuberculosis.
Infect. Immun.
57:3123-3130 |
| 13. | Clemens, D. L. 1996. Characterization of the Mycobacterium tuberculosis phagosome. Trends Microbiol. 4:113-118[CrossRef][Medline]. |
| 14. | Fellay, R., J. Frey, and H. Krisch. 1987. Interposon mutagenesis of soil and water bacteria: a family of DNA fragments designed for in vitro insertional mutagenesis of gram-negative bacteria. Gene 52:147-154[CrossRef][Medline]. |
| 15. | Harth, G., B. Lee, J. Wang, D. L. Clemens, and M. A. Horwitz. 1996. Novel insights into the genetics, biochemistry, and immunocytochemistry of the 30-kilodalton major extracellular protein of Mycobacterium tuberculosis. Infect. Immun. 64:3038-3047[Abstract]. |
| 16. | Hayat, M. 1986. Principles and techniques of electron microscopy: biological applications, vol. 1. Litton Educational Publishing, Inc., New York, N.Y. |
| 17. |
Husson, R. N.,
B. E. James, and R. A. Young.
1990.
Gene replacement and expression of foreign DNA in mycobacteria.
J. Bacteriol.
172:519-524 |
| 18. | Huygen, K., J. Content, O. Denis, D. L. Montgomery, A. M. Yawman, R. R. Deck, C. M. DeWitt, I. M. Orme, S. Baldwin, D. S. C. A. Drowart, E. Lozes, P. Vandenbussche, J. P. Van Vooren, M. A. Liu, and J. B. Ulmer. 1996. Immunogenicity and protective efficacy of a tuberculosis DNA vaccine. Nat. Med. 2:893-898[CrossRef][Medline]. |
| 19. | Jackson, M., C. Raynaud, M. A. Laneelle, C. Guilhot, C. Laurent-Winter, D. Ensergueix, B. Gicquel, and M. Daffe. 1999. Inactivation of the antigen 85C gene profoundly affects the mycolate content and alters the permeability of the Mycobacterium tuberculosis cell envelope. Mol. Microbiol. 31:1573-1587[CrossRef][Medline]. |
| 20. | Jacobs, W. R., Jr., G. V. Kalpana, J. D. Cirillo, L. Pascopella, S. B. Snapper, R. A. Udani, W. Jones, R. G. Barletta, and B. R. Bloom. 1991. Genetic systems for mycobacteria. Methods Enzymol. 204:537-555[Medline]. |
| 21. | Jagannath, C., J. A. Actor, and R. L. Hunter. 1998. Induction of nitric oxide in human monocytes and monocyte cell lines by Mycobacterium tuberculosis. Nitric oxide 2:174-186. |
| 22. | Jagannath, C., H. S. Allaudeen, and R. L. Hunter. 1995. Activities of poloxamer CRL8131 against Mycobacterium tuberculosis in vitro and in vivo. Antimicrob. Agents Chemother. 39:1349-1354[Abstract]. |
| 23. |
Kalpana, G. V.,
B. R. Bloom, and W. R. Jacobs, Jr.
1991.
Insertional mutagenesis and illegitimate recombination in mycobacteria.
Proc. Natl. Acad. Sci. USA
88:5433-5437 |
| 24. | Kochi, A. 1991. The global tuberculosis situation and the new control strategy of the World Health Organization. Tubercle 72:1-12[CrossRef][Medline]. |
| 25. | Kubica, G., and L. Wayne (ed.). 1984. The Mycobacteria: a sourcebook, vol. 15. Marcel Dekker, Inc., New York, N.Y. |
| 26. | Norman, E., O. A. Dellagostin, J. McFadden, and J. W. Dale. 1995. Gene replacement by homologous recombination in Mycobacterium bovis BCG. Mol. Microbiol. 16:755-760[CrossRef][Medline]. |
| 27. |
Norris, S. J.,
C. J. Carter,
J. K. Howell, and A. G. Barbour.
1992.
Low-passage-associated proteins of Borrelia burgdorferi B31: characterization and molecular cloning of OspD, a surface-exposed, plasmid-encoded lipoprotein.
Infect. Immun.
60:4662-4672 |
| 28. | Patti, J. M., B. L. Allen, M. J. McGavin, and M. Hook. 1994. MSCRAMM-mediated adherence of microorganisms to host tissues. Annu. Rev. Microbiol. 48:585-617[Medline]. |
| 29. |
Pavelka, M. S., Jr., and W. R. Jacobs, Jr.
1999.
Comparison of the construction of unmarked deletion mutations in Mycobacterium smegmatis, Mycobacterium bovis bacillus Calmette-Guérin, and Mycobacterium tuberculosis H37Rv by allelic exchange.
J. Bacteriol.
181:4780-4789 |
| 30. |
Pelicic, V.,
M. Jackson,
J. M. Reyrat,
W. R. Jacobs, Jr.,
B. Gicquel, and C. Guilhot.
1997.
Efficient allelic exchange and transposon mutagenesis in Mycobacterium tuberculosis.
Proc. Natl. Acad. Sci. USA
94:10955-10960 |
| 31. |
Ratliff, T. L.,
R. McCarthy,
W. B. Telle, and E. J. Brown.
1993.
Purification of a mycobacterial adhesin for fibronectin.
Infect. Immun.
61:1889-1894 |
| 32. | Ratliff, T. L., J. A. McGarr, C. Abou-Zeid, G. A. Rook, J. L. Stanford, J. Aslanzadeh, and E. J. Brown. 1988. Attachment of mycobacteria to fibronectin-coated surfaces. J. Gen. Microbiol. 134:1307-1313[Medline]. |
| 33. |
Reyrat, J. M.,
F. X. Berthet, and B. Gicquel.
1995.
The urease locus of Mycobacterium tuberculosis and its utilization for the demonstration of allelic exchange in Mycobacterium bovis bacillus Calmette-Guerin.
Proc. Natl. Acad. Sci. USA
92:8768-8772 |
| 34. | Sambrook, J., E. F. Fritsch, and T. Maniatis. 1989. Molecular cloning: a laboratory manual, 2nd ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y. |
| 35. | Wilson, T., B. J. Wards, S. J. White, B. Skou, G. W. de Lisle, and D. M. Collins. 1997. Production of avirulent Mycobacterium bovis strains by illegitimate recombination with deoxyribonucleic acid fragments containing an interrupted ahpC gene. Tuber. Lung Dis. 78:229-235[CrossRef][Medline]. |
| 36. | Young, D. B., S. H. E. Kaufmann, P. W. M. Hermans, and J. E. R. Thole. 1992. Mycobacterial protein antigens: a compilation. Mol. Microbiol. 6:133-145[Medline]. |
This article has been cited by other articles: